Intercure Ltd (INCR) Gross Profit Margin starting from the fourth quarter 2025 to fourth quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Intercure Ltd   (NASDAQ: INCR)


Intercure Ltd 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INCR Gross Profit Margin (Dec 31 2025)
Q4 		0
Q3 		0
Q2 		0
Q1 		(Dec 31 2024)
Q4
Y / Y Revenue Change 318.38 %
Seq. Revenue Change -
Revenue In Millions $270.20
Gross Profit Margin 12.28 %
Gross Profit Margin Total Ranking # 3452
Gross Profit In Millions $33.18
Y / Y Gross Profit Change 305.9 %
Seq. Gross Profit Change -


Commenting fourth quarter 2025 Gross Profit Margin



Observing fourth quarter 2025 results within Major Pharmaceutical Preparations industry 154 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 3452.
Learn about Gross Margin
INCR's Gross Profit Margin fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 155
Healthcare Sector # 466
Overall # 3431

Gross Profit Margin Statistics
High Average Low
41.48 % 27.18 % 12.28 %
(Dec 31 2021)   (Dec 31 2025)


INCR Gross Income Trends • More of INCR's Profitabilty Ratios • INCR Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
INCR's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
INCR's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for INCR's Competitors
Gross Profit Margin Profit Margin for Intercure Ltd 's Suppliers
Gross Profit Margin Profit Margin for INCR's Customers

You may also want to know
INCR's Annual Growth Rates INCR's Profitability Ratios INCR's Asset Turnover Ratio INCR's Dividend Growth
INCR's Roe INCR's Valuation Ratios INCR's Financial Strength Ratios INCR's Gross Profit Growth
INCR's Roa INCR's Inventory Turnover Ratio INCR's Growth Rates INCR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2025, within Major Pharmaceutical Preparations Industry Gross Profit MarginDec 31 2025 MRQ Gross ProfitDec 31 2025 MRQ Revenue
Perrigo Company Plc  32.64 %$ 362.200  Millions$ 1,109.600  Millions
Jaguar Health Inc   31.99 %$ 1.035  Millions$ 3.235  Millions
Prophase Labs Inc   31.51 %$ 0.247  Millions$ 0.784  Millions
Viatris Inc   30.99 %$ 1,147.900  Millions$ 3,703.600  Millions
Maravai Lifesciences Holdings Inc   25.64 %$ 12.842  Millions$ 50.088  Millions
Inmed Pharmaceuticals Inc  22.46 %$ 0.184  Millions$ 0.820  Millions
Siga Technologies Inc  21.20 %$ 0.804  Millions$ 3.794  Millions
Rockwell Medical inc   19.51 %$ 3.878  Millions$ 19.878  Millions
Bio Green Med Solution Inc   18.17 %$ 0.121  Millions$ 0.666  Millions
Evotec Se  14.49 %$ 127.928  Millions$ 882.978  Millions
China Pharma Holdings Inc  12.30 %$ 0.151  Millions$ 1.226  Millions
Intercure Ltd   12.28 %$ 33.181  Millions$ 270.200  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.